Ttk Healthcare Limited Stock Current Valuation
| TTKHLTCARE | 1,497 48.40 3.34% |
Valuation analysis of TTK Healthcare helps investors to measure TTK Healthcare's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At present, TTK Healthcare's Cash And Short Term Investments are projected to increase significantly based on the last few years of reporting. The current year's Change In Cash is expected to grow to about 8 B, whereas Begin Period Cash Flow is forecasted to decline to about 93.2 M. Fundamental drivers impacting TTK Healthcare's valuation include:
Price Book 2.036 | Enterprise Value 12.2 B | Enterprise Value Ebitda 10.2137 | Price Sales 2.7605 | Trailing PE 26.4537 |
Fairly Valued
Today
Please note that TTK Healthcare's price fluctuation is very steady at this time. Calculation of the real value of TTK Healthcare is based on 3 months time horizon. Increasing TTK Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since TTK Healthcare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of TTK Stock. However, TTK Healthcare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1496.75 | Real 1485.8 | Hype 1496.55 | Naive 1538.76 |
The real value of TTK Stock, also known as its intrinsic value, is the underlying worth of TTK Healthcare Company, which is reflected in its stock price. It is based on TTK Healthcare's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of TTK Healthcare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of TTK Healthcare Limited helps investors to forecast how TTK stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of TTK Healthcare more accurately as focusing exclusively on TTK Healthcare's fundamentals will not take into account other important factors: TTK Healthcare Limited Company Current Valuation Analysis
TTK Healthcare's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current TTK Healthcare Current Valuation | 12.19 B |
Most of TTK Healthcare's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, TTK Healthcare Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, TTK Healthcare Limited has a Current Valuation of 12.19 B. This is 15.13% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current valuation for all India stocks is 26.67% higher than that of the company.
TTK Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses TTK Healthcare's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of TTK Healthcare could also be used in its relative valuation, which is a method of valuing TTK Healthcare by comparing valuation metrics of similar companies.TTK Healthcare is currently under evaluation in current valuation category among its peers.
TTK Fundamentals
| Return On Equity | 0.0795 | ||||
| Return On Asset | 0.0114 | ||||
| Profit Margin | 0.10 % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 12.19 B | ||||
| Shares Outstanding | 14.13 M | ||||
| Shares Owned By Insiders | 75.60 % | ||||
| Shares Owned By Institutions | 2.69 % | ||||
| Price To Book | 2.04 X | ||||
| Price To Sales | 2.76 X | ||||
| Revenue | 7.53 B | ||||
| Gross Profit | 3.77 B | ||||
| EBITDA | 999.35 M | ||||
| Net Income | 628.42 M | ||||
| Total Debt | 228.11 M | ||||
| Book Value Per Share | 734.95 X | ||||
| Cash Flow From Operations | (49.43 M) | ||||
| Earnings Per Share | 56.58 X | ||||
| Number Of Employees | 1.32 K | ||||
| Beta | 0.65 | ||||
| Market Capitalization | 21.29 B | ||||
| Total Asset | 12.01 B | ||||
| Retained Earnings | 8.75 B | ||||
| Working Capital | 8.81 B | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 12.01 B |
About TTK Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze TTK Healthcare Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of TTK Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of TTK Healthcare Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in TTK Stock
TTK Healthcare financial ratios help investors to determine whether TTK Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in TTK with respect to the benefits of owning TTK Healthcare security.